First-line Advanced Cutaneous Melanoma Treatments: Where Do We Stand?

Cutaneous melanoma has always been a dreaded diagnosis because of its high mortality rate and its proclivity for invasiveness and metastasis. Historically, advanced melanoma treatment has been limited to chemotherapy and nonspecific immunotherapy agents that display poor curative potential and high...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdulkarim, Louay S, Motley, Richard J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2021
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717133/
https://www.ncbi.nlm.nih.gov/pubmed/34914610
http://dx.doi.org/10.2196/29912

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717133/
https://www.ncbi.nlm.nih.gov/pubmed/34914610
http://dx.doi.org/10.2196/29912

Ejemplares similares